| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |